Emerging market (EM) equities continue to be the benefactors of a weaker dollar, giving traders plenty of profitable opportunities in EM. Single-country ETFs are in play, with two traders may want to ponder: the Direxion Daily South Korea Bull 3X Shares (KORU) and the Direxion Daily MSCI Mexico Bull 3X Shares (MEXX).
The Direxion Daily MSCI South Korea Bull 3X Shares aims for 300% daily returns of the MSCI Korea 25/50 Index but is risky as a long term hold. This ETF can yield significant gains during bull runs but can also incur substantial losses during downturns, as seen in Q4 2024. South Korea's stock market has rebounded from December lows but faces economic and political uncertainties, making short-term pullbacks likely.
KORU Medical Systems' stock has surged 60% since November, driven by the success of its FREEDOM System for subcutaneous immunoglobulin delivery. The SCIg market is growing rapidly, with KORU outperforming competitors by capturing market share and benefiting from trends like prefilled syringes. Strong international growth, new therapies, and product innovations are key drivers, with significant revenue from recurring patients and promising future launches.
KORU Medical Systems is poised for growth with solid revenue increases, multiple growth drivers, and a chance to reach cash flow breakeven in Q4. The FREEDOM system, designed for at-home drug delivery, offers recurring revenue from consumables and is gaining market share in the SCIg market. International expansion and novel therapies present significant growth opportunities, with international revenue growing 46% and novel therapies progressing to Phase 3 trials.
Opportunities in China might be the first place to look for emerging market (EM) trade opportunities. But South Korea shouldn't be overlooked.